867202-89-9Relevant academic research and scientific papers
Aryl-Heteroaryl Derivatives as Novel Wake-Promoting Agents
Lesur, Brigitte,Lin, Yin G.,Marcy, Val R.,Aimone, Lisa D.,Gruner, John,Bacon, Edward R.,Chatterjee, Sankar
, p. 429 - 432 (2013/03/29)
In search of a next generation molecule to the novel wake-promoting agent modafinil, a series of aryl-heteroayl-derived wakefulness enhancing agents (in rats) was developed. From this work, compound 16 was separated into its enantiomers to profile them individually.
Wake-promoting agents: Search for next generation modafinil: Part i
Dunn, Derek,Hostetler, Greg,Iqbal, Mohamed,Messina-Mclaughlin, Patricia,Reiboldt, Alyssa,Lin, Yin Guo,Gruner, John,Bacon, Edward R.,Ator, Mark A.,Chatterjee, Sankar
, p. 2312 - 2314 (2012/05/04)
In search of a next generation molecule to the novel wake promoting agent modafinil, a series of bi-phenyl derived wakefulness enhancing agents (in rat) was developed. From this work, compound 17 has been selected for additional studies.
ORGANIC COMPOUNDS
-
Page/Page column 87-88, (2008/12/06)
The present invention provides a compound of formula I: said compound is inhibitor of aldosterone synthase (CYP11B2), and/or 11beta-hydroxylase (CYP11B1), and/or aromatase, and thus can be employed for the treatment of a disorder or disease mediated by al
Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
-
Page/Page column 23, (2008/06/13)
The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions that include substituted biaryl-methanesulfinyl acetamides of Formula
